FMC-242

N/A

Report date: 2025/10/20 14:18:41
NME

Base Information

Drug NameFMC-242
Drug Alias NameFMC-242
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitorsGTPase Ras inhibitors
TargetsPhosphatidylinositol 3 kinase alphaGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFrontier Medicines Corp
China Registration ClassN/A

Develop Information

Active CompaniesFrontier Medicines Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A